Author

W. M. Rideout

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:clustering· 2 Approach:experimental assay· 2 Organism:mouse· 2 Approach:wet-lab / biochemical assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

S. Naranjo· 2 shared T. Jacks· 2 shared A. Bhutkar· 1 shared A. Jin· 1 shared A. M. Cruz· 1 shared A. M. Jaeger· 1 shared C. S. McGinnis· 1 shared D. A. Canner· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

S. Naranjo

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Lineage Recording Reveals the Phylodynamics, Plasticity and Paths of Tumor Evolution

D. Yang, M. G. Jones, S. Naranjo, W. M. Rideout, K. H. J. Min, R. Ho, W. Wu, J. M. Replogle, J. L. Page, J. J. Quinn, F. Horns, X. Qiu, M. Z. Chen, W. A. Freed-Pastor, C. S. McGinnis, , J. S. Weissman

The paper tracks tumor evolution in a mouse model using lineage tracing and single-cell RNA-seq, revealing plasticity, fitness-associated programs, and stereotypical evolutionary trajectories.

bioRxiv · Oct 12, 2021 · PreprintCancer Biology

Mismatch repair deficiency is not sufficient to increase tumor immunogenicity

P. M. K. Westcott, F. Muyas, O. Smith, H. Hauck, N. J. Sacks, Z. A. Ely, A. M. Jaeger, W. M. Rideout, A. Bhutkar, D. Zhang, M. C. Beytagh, D. A. Canner, R. T. Bronson, S. Naranjo, A. Jin, , T. Jacks

This study shows that MMRd in mouse tumor models does not increase immunogenicity or ICB response, due to intratumoral heterogeneity.

bioRxiv · Aug 24, 2021 · PreprintCancer Biology